X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3592) 3592
Publication (301) 301
Book Chapter (73) 73
Book Review (62) 62
Conference Proceeding (5) 5
Dissertation (4) 4
Book / eBook (3) 3
Magazine Article (2) 2
Government Document (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2668) 2668
index medicus (1724) 1724
hematology (1234) 1234
female (1100) 1100
male (1062) 1062
peripheral vascular disease (773) 773
animals (769) 769
activated protein-c (704) 704
middle aged (666) 666
adult (654) 654
activated factor-vii (567) 567
thrombin (550) 550
coagulation (536) 536
activated clotting time (497) 497
thrombosis (482) 482
aged (458) 458
anticoagulants (391) 391
risk factors (391) 391
surgery (323) 323
partial thromboplastin time (319) 319
tissue factor (316) 316
heparin (314) 314
activated partial thromboplastin time (293) 293
blood coagulation - drug effects (292) 292
cardiac & cardiovascular systems (290) 290
mutation (290) 290
cardiopulmonary bypass (275) 275
hemostasis (272) 272
analysis (271) 271
blood coagulation (268) 268
venous thrombosis (263) 263
anticoagulants - therapeutic use (257) 257
factor v - genetics (252) 252
blood (248) 248
recombinant proteins - therapeutic use (243) 243
proteins (236) 236
plasma (235) 235
prothrombin time (233) 233
adolescent (230) 230
blood coagulation tests (227) 227
anticoagulation (226) 226
health aspects (222) 222
protein c (222) 222
thrombin generation (217) 217
inflammation (213) 213
thrombophilia (208) 208
hemophilia (202) 202
treatment outcome (200) 200
mice (199) 199
thromboembolism (197) 197
prothrombin (196) 196
venous thromboembolism (196) 196
factor-v-leiden (194) 194
hemorrhage (194) 194
pregnancy (193) 193
research (190) 190
medicine & public health (187) 187
pharmacology & pharmacy (180) 180
prospective studies (180) 180
recombinant factor viia (178) 178
anesthesiology (173) 173
blood-coagulation (173) 173
risk (172) 172
care and treatment (169) 169
activated protein c (167) 167
article (167) 167
dose-response relationship, drug (167) 167
anticoagulants - administration & dosage (166) 166
platelets (166) 166
resistance (165) 165
prothrombin complex concentrate (162) 162
biochemistry & molecular biology (160) 160
case-control studies (159) 159
management (159) 159
time factors (158) 158
factor viia - therapeutic use (157) 157
therapy (157) 157
child (156) 156
aged, 80 and over (153) 153
cell biology (153) 153
anticoagulants - pharmacology (151) 151
disseminated intravascular coagulation (146) 146
anticoagulants - adverse effects (145) 145
heparin - administration & dosage (144) 144
bleeding (143) 143
inhibitors (140) 140
thrombin - metabolism (140) 140
retrospective studies (139) 139
rats (137) 137
blood coagulation - physiology (134) 134
hematology, oncology and palliative medicine (132) 132
hemophilia a - drug therapy (132) 132
protein c - metabolism (131) 131
activated platelets (130) 130
fibrin (129) 129
activated protein c resistance (128) 128
fibrinolysis (126) 126
mortality (125) 125
factor viia (123) 123
whole blood coagulation time (123) 123
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3598) 3598
German (26) 26
French (18) 18
Japanese (18) 18
Korean (6) 6
Chinese (5) 5
Russian (4) 4
Turkish (4) 4
Czech (1) 1
Italian (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2019, Volume 17, Issue 1, pp. 138 - 148
Summary Essentials Performance of the one‐stage clotting (OSC) assay varies with the clotting activator used. Recombinant FIX‐albumin fusion protein (rIX‐FP)... 
multicenter study | factor IX | activated partial thromboplastin time | blood coagulation tests | hemophilia B | DISCREPANCIES | factor IX | DIAGNOSIS | hemophilia B | PERIPHERAL VASCULAR DISEASE | CHROMOGENIC ASSAYS | MODIFIED FACTOR-VIII | RIX-FP | HEMATOLOGY | Thromboplastin | Coagulation factors | Proteins | Fc receptors | Coagulation factor IX | Laboratories | Actin | Hemophilia | Albumin | Fusion protein | Clotting | Kaolin
Journal Article
Journal Article
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2013, Volume 992, pp. 155 - 167
The standard assay for monitoring anticoagulation during extracorporeal life support (ECLS) is the activated clotting time (ACT) test, with celite, kaolin, and... 
MAX-ACT | Activated clotting time | Coagulation monitoring | Hemotec | Hemochron | Whole blood coagulation time | Anticoagulants | Humans | Blood Coagulation | Glass | Diatomaceous Earth | Hemostatics | Whole Blood Coagulation Time | Kaolin
Conference Proceeding
Thrombosis Research, ISSN 0049-3848, 07/2019, Volume 179, pp. 69 - 72
Clotting test results are currently not useful for estimating direct oral anti-coagulant (DOAC) concentrations because baseline results vary. DOAC Stop is a... 
Correction Ratio | Rivaroxaban | Activated partial thromboplastin time (aPTT) | DOACs | Apixaban | Dabigatran | DOAC Stop | Dilute Russells viper venom time (dRVVT) | Poisonous snakes | Medical examination | Chemical tests and reagents | Thrombosis | Blood | Blood clot
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2014, Volume 7, Issue 2, pp. 140 - 151
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 12/2015, Volume 13, Issue 12, pp. 2168 - 2179
Journal Article
Journal Article
Critical Reviews in Biochemistry and Molecular Biology, ISSN 1040-9238, 07/2015, Volume 50, Issue 4, pp. 326 - 336
The plasma coagulation system in mammalian blood consists of a cascade of enzyme activation events in which serine proteases activate the proteins (proenzymes... 
contact pathway | polyphosphate | Blood coagulation | tissue factor | factor VII | factor XII |